Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,251 results that match your search.22,251 results
  • Russian law guards the rights of performers. This general statement is echoed in the activities of a number of organisations for collective rights management. One such organisation is the All-Russian Society for Intellectual Property. Ironically, its Russian acronym is VOIS which is the same as the Russian acronym VOIS for World Intellectual Property Organization.
  • How can computer games makers obtain patent protection in Europe? Pete Sadler assesses decisions by the EPO and explains the Office’s thinking
  • Michael Nixon, Cheah Yew Kuin and Chew Kherk Ying explain the IP valuation process and how governments in Southeast Asia are looking to provide IP owners opportunities to use their intellectual property to finance growth
  • Article 123(2) EPC specifies that a "European patent application or European patent may not be amended in such a way that it contains subject-matter which extends beyond the content of the application as filed". The aim is to prevent applicants from improving their position, and to protect the legal security of third parties.
  • The European Commission has adopted a new Technology Transfer Block Exemption Regulation (TTBER) and new Technology Transfer Guidelines for the assessment of technology transfer agreements under EU antitrust rules with effect from May 1 2014. Although the TTBER provides for rather substantial restrictions on the stipulations in technology transfer agreements compared to the former TTBER 2004, many of the modifications that were laid down in the first drafts (such as adaption of the market-share thresholds) did not subsequently enter into force. The main changes introduced by the new TTBER are discussed below.
  • The Federal Circuit’s decision in Sandoz v Amgen will lead to biosimilar companies looking to use PTAB proceedings more to invalidate drug patents, because it is now harder for them to bring district court actions before filing biosimilar applications
  • With new USPTO guidance on Alice v CLS impending, companies applying for patents have been caught between waiting to file to take the guidance into account and making sure they are first to file. Alan Wright assesses how prosecution has been affected since Alice
  • Michelle Lee provided details on the USPTO’s guidance on eligible subject matter in light of Alice at a Senate confirmation hearing, but Senator Grassley indicated that members of the next Congress should be given the chance to ask questions before she can be confirmed
  • The Organisation Africaine de la Propriété Intellectuelle (OAPI) became the 93rd member of the Madrid System on December 5
  • The EPO’s Administrative Council meets in Munich this week against a backdrop of strikes, protests and public letters criticising the Office